ITGR Operating Cash Flow
$205.44MTTM · USD
Period ending:
ITGR FY Operating Cash FlowUSD
$205.21M$0.00
1999-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
ITGR operating cash flow history
Cash generated from core business operations. The available annual fiscal periods series contains 27 observations from Dec 31, 1999 to Dec 31, 2025.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| 196,148,000 | |
| 205,205,000 | |
| 180,213,000 | |
| 116,381,000 | |
| 156,666,000 | |
| 181,341,000 | |
| 165,358,000 | |
| 167,299,000 | |
| 149,357,000 | |
| 105,532,000 | |
| 12,479,000 | |
| 81,276,000 | |
| 56,755,000 | |
| 64,831,000 | |
| 89,921,000 | |
| 76,885,000 | |
| 71,766,000 | |
| 57,101,000 | |
| 42,965,000 | |
| 39,205,000 | |
| 43,335,000 | |
| 45,166,000 | |
| 54,801,000 | |
| 27,810,000 | |
| 21,455,000 | |
| 18,160,000 | |
| 8,992,000 |
Compare operating cash flow
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) operating cash flow
- Bridgebio Pharma Inc (BBIO) operating cash flow
- Brightspring Health Services Inc (BTSG) operating cash flow
- Madrigal Pharmaceuticals Inc (MDGL) operating cash flow
- Ensign Group Inc (ENSG) operating cash flow
- Glaukos Corp (GKOS) operating cash flow
- Vaxcyte Inc (PCVX) operating cash flow
- Krystal Biotech Inc (KRYS) operating cash flow
All ITGR financial metrics · ITGR stock overview · How to interpret financial metrics
